Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration

Insup Choi1, Yuanxi Zhang1, Steven P Seegobin1

  • 1Departments of Neurology and Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.

Nature Communications
|March 15, 2020
PubMed

Insights

Microglia protect the brain by clearing toxic alpha-synuclein via a process called synucleinphagy. Disrupting this pathway leads to neurodegeneration, highlighting microglia

Area of Science:

  • Neuroscience
  • Cell Biology
  • Immunology

Background:

  • Microglia are crucial for maintaining brain homeostasis by clearing cellular debris.
  • The role of microglia in neurodegenerative diseases, particularly in clearing alpha-synuclein, is not fully understood.
  • Accumulation of misfolded alpha-synuclein is a hallmark of several neurodegenerative disorders.

Purpose of the Study:

  • To investigate the neuroprotective role of microglia in clearing neuron-released alpha-synuclein.
  • To elucidate the molecular mechanisms underlying microglial alpha-synuclein clearance, specifically selective autophagy (synucleinphagy).

Main Methods:

  • Activation of microglia by neuronal alpha-synuclein.
  • Engulfment of alpha-synuclein into autophagosomes for degradation via selective autophagy (synucleinphagy).
  • Investigated the role of Toll-like receptor 4 (TLR4), NF-κB signaling, and p62/SQSTM1 in synucleinphagy.
  • Utilized mouse models expressing human alpha-synuclein to study the impact of disrupted microglial autophagy on dopaminergic neuron degeneration.

Main Results:

  • Neuronal alpha-synuclein activates microglia to initiate synucleinphagy, a selective autophagy pathway for alpha-synuclein degradation.
  • Microglial synucleinphagy is dependent on Toll-like receptor 4 (TLR4), which upregulates p62/SQSTM1 via NF-κB signaling.
  • p62/SQSTM1 is essential for the formation of ubiquitinated alpha-synuclein aggregates targeted for autophagic degradation.
  • Disruption of microglial autophagy in mice leads to alpha-synuclein accumulation and dopaminergic neuron loss.

Conclusions:

  • Microglia exert a neuroprotective effect by clearing toxic alpha-synuclein through TLR4-NF-κB-p62 mediated synucleinphagy.
  • This study identifies a critical mechanism for preventing alpha-synuclein aggregation and subsequent neurodegeneration.
  • Targeting microglial synucleinphagy represents a potential therapeutic strategy for alpha-synucleinopathies.